معرفی
Leila Rostami is a PhD Researcher at Åbo Akademi University's Faculty of Science and Engineering, actively contributing to antimicrobial resistance research. Her work aligns with UN Sustainable Development Goals focused on health and well-being.
Her research expertise spans critical areas in antimicrobial science:
- Antibiotic Resistance mechanisms
- Antimicrobial Resistance dynamics
- Antibacterial Activity profiling
- Pathogen behavior studies
- Microbiome interactions
- Antibiotic Stewardship frameworks
Current research trends show concentrated focus on novel therapeutic approaches for multidrug-resistant pathogens, particularly through review analyses of emerging drug delivery systems and resistance mechanisms. Her 2025 publication examines next-generation strategies against resistant bacterial strains.
Rostami participates in major collaborative initiatives and maintains active research networks across Nordic institutions.
She serves as Co-Investigator in the MADNESS Centre of Excellence project and conducted a visiting research period at the University of Helsinki's Division of Pharmaceutical Biosciences (October-November 2024).
Her laboratory work centers on the Åbo Akademi-led MADNESS initiative, which develops materials-driven solutions for antimicrobial resistance through interdisciplinary collaboration involving 25+ researchers across pharmaceutical biosciences and engineering disciplines.
